Search research articles
Contact Us
Filters
Showing results (31-40 of 69) with videos related to
Page
of 7
Sort By:
International Journal of Molecular Sciences
|
November 6, 2020
Brain Distribution of Dual ABCB1/ABCG2 Substrates Is Unaltered in a Beta-Amyloidosis Mouse Model
Thomas Wanek, Viktoria Zoufal, Mirjam Brackhan, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
December 23, 2022
Knockout of ABCC1 in NCI-H441 cells reveals CF to be a suboptimal substrate to study MRP1 activity in organotypic in vitro models
Johannes A Sake, Mohammed Ali Selo, Lyubomyr Burtnyak, et al.
Pharmaceuticals (Basel, Switzerland)
|
April 27, 2024
Functionalization of <sup>68</sup>Ga-Radiolabeled Nanodiamonds with Octreotide Does Not Improve Tumor-Targeting Capabilities
Thomas Wanek, Marco Raabe, Md Noor A Alam, et al.
Epilepsy Research
|
February 21, 2012
The antiepileptic drug mephobarbital is not transported by P-glycoprotein or multidrug resistance protein 1 at the blood-brain barrier: a positron emission tomography study
Severin Mairinger, Jens P Bankstahl, Claudia Kuntner, et al.
Nuclear Medicine and Biology
|
June 19, 2013
Assessment of cerebral P-glycoprotein expression and function with PET by combined [11C]inhibitor and [11C]substrate scans in rats
Julia Müllauer, Rudolf Karch, Jens P Bankstahl, et al.
Nuclear Medicine and Biology
|
September 18, 2012
Synthesis and preclinical evaluation of the radiolabeled P-glycoprotein inhibitor [(11)C]MC113
Severin Mairinger, Thomas Wanek, Claudia Kuntner, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
February 11, 2023
Influence of P-glycoprotein on pulmonary disposition of the model substrate [<sup>11</sup>C]metoclopramide assessed by PET imaging in rats
Severin Mairinger, Irene Hernández-Lozano, Thomas Filip, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 6, 2016
Strategies to Inhibit ABCB1- and ABCG2-Mediated Efflux Transport of Erlotinib at the Blood-Brain Barrier: A PET Study on Nonhuman Primates
Nicolas Tournier, Sebastien Goutal, Sylvain Auvity, et al.
Alzheimer'S Research & Therapy
|
October 17, 2021
Characterization of an APP/tau rat model of Alzheimer's disease by positron emission tomography and immunofluorescent labeling
Thomas Filip, Severin Mairinger, Joerg Neddens, et al.
Nuclear Medicine and Biology
|
June 3, 2017
[<sup>11</sup>C]Erlotinib PET cannot detect acquired erlotinib resistance in NSCLC tumor xenografts in mice
Alexander Traxl, Taraneh Beikbaghban, Thomas Wanek, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 69) with videos related to
Sort By:
Page
of 7
International Journal of Molecular Sciences
|
November 6, 2020
Brain Distribution of Dual ABCB1/ABCG2 Substrates Is Unaltered in a Beta-Amyloidosis Mouse Model
Thomas Wanek, Viktoria Zoufal, Mirjam Brackhan, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
December 23, 2022
Knockout of ABCC1 in NCI-H441 cells reveals CF to be a suboptimal substrate to study MRP1 activity in organotypic in vitro models
Johannes A Sake, Mohammed Ali Selo, Lyubomyr Burtnyak, et al.
Pharmaceuticals (Basel, Switzerland)
|
April 27, 2024
Functionalization of <sup>68</sup>Ga-Radiolabeled Nanodiamonds with Octreotide Does Not Improve Tumor-Targeting Capabilities
Thomas Wanek, Marco Raabe, Md Noor A Alam, et al.
Epilepsy Research
|
February 21, 2012
The antiepileptic drug mephobarbital is not transported by P-glycoprotein or multidrug resistance protein 1 at the blood-brain barrier: a positron emission tomography study
Severin Mairinger, Jens P Bankstahl, Claudia Kuntner, et al.
Nuclear Medicine and Biology
|
June 19, 2013
Assessment of cerebral P-glycoprotein expression and function with PET by combined [11C]inhibitor and [11C]substrate scans in rats
Julia Müllauer, Rudolf Karch, Jens P Bankstahl, et al.
Nuclear Medicine and Biology
|
September 18, 2012
Synthesis and preclinical evaluation of the radiolabeled P-glycoprotein inhibitor [(11)C]MC113
Severin Mairinger, Thomas Wanek, Claudia Kuntner, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
February 11, 2023
Influence of P-glycoprotein on pulmonary disposition of the model substrate [<sup>11</sup>C]metoclopramide assessed by PET imaging in rats
Severin Mairinger, Irene Hernández-Lozano, Thomas Filip, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 6, 2016
Strategies to Inhibit ABCB1- and ABCG2-Mediated Efflux Transport of Erlotinib at the Blood-Brain Barrier: A PET Study on Nonhuman Primates
Nicolas Tournier, Sebastien Goutal, Sylvain Auvity, et al.
Alzheimer'S Research & Therapy
|
October 17, 2021
Characterization of an APP/tau rat model of Alzheimer's disease by positron emission tomography and immunofluorescent labeling
Thomas Filip, Severin Mairinger, Joerg Neddens, et al.
Nuclear Medicine and Biology
|
June 3, 2017
[<sup>11</sup>C]Erlotinib PET cannot detect acquired erlotinib resistance in NSCLC tumor xenografts in mice
Alexander Traxl, Taraneh Beikbaghban, Thomas Wanek, et al.
Page
of 7